期刊文献+

胰岛素无水反胶束油溶液的体外性质及对正常大鼠的降血糖作用考察

In vitro characteristics and hypoglycemic effects of insulin anhydrous reversed micelles
下载PDF
导出
摘要 目的为进一步的制剂研究奠定基础。方法观察油溶液遇水乳化后的形态、粒径分布,采用HPLC法测定不同稀释倍数和不同pH值下油溶液的释放度,采用单因素方差分析法比较大鼠给药组(40U·kg-1)与空白组间各时间点血糖水平的差异,计算相对药理生物利用度。结果油溶液乳化后平均粒径为(2.45±1.43)μm;稀释倍数升高会略增加胰岛素的释放,在pH2.0的稀释介质中胰岛素释放得最多;灌胃组血糖没有显著性变化(P】0.05);十二指肠给药组的相对生物利用度为4.41%。结论胰岛素油溶液在胃肠道中能够自乳化,灌胃给药组没有显著的降血糖作用,十二指肠给药组降糖效果显著,胰岛素在肠道的吸收较胃部的吸收好。 Objectives To investigate the in vitro characteristics of insulin anhydrous reversed micelles (ARMs) and its in vivo hypoglycemic effects in normal rats. Methods The size distribution of the emulsion after insulin anhydrous reversed micelles being emulsified was studied and its release behavior in different dilution volumes and pH media was investigated. The difference of blood glucose level among rendered groups and blank group at each time point was examined using one-way analysis of variance and the relative pharmacological bioavailability was calculated. Results The mean diameter of ARMs was (2.45±1.43) μm. The maximum release of insulin appeared in acidic medium and the dilution volume slightly affected the release. In contrast to intro stomach, the intro duodenum group had significant hypoglycemic effect with relative bioavailability of 4.41 %. Conclusions The insulin anhydrous reversed micelles can be self-emulsified in gastrointestinal tracts and can be absorbed efficiently in intestinal tract to produce significant reduction of blood glucose.
出处 《中国药剂学杂志(网络版)》 2009年第6期442-447,共6页 Chinese Journal of Pharmaceutics:Online Edition
基金 国家自然科学基金资助项目(30672555)
关键词 药剂学 无水反胶束油溶液 高效液相色谱法 胰岛素 相对生物利用度 pharmaceutics anhydrous reversed micelles HPLC insulin relative bioavailability
  • 相关文献

参考文献9

  • 1张立强,陶安进,石凯,寸冬梅,崔福德,郑俊民.肠溶包衣胰岛素-壳聚糖复合物纳米粒的制备及体内外性质[J].沈阳药科大学学报,2006,23(2):65-69. 被引量:15
  • 2LI Chun-lei,,DENG Ying-Jie.Oil-based formulations for oral delivery of insulin. Journal of Pharmaceutical Sciences . 2004
  • 3YIN Li-chen,DING Jie-ying,FEI Li-kun.Beneficial properties for insulin absorption using superporous hydrogelcontaining interpenetrating polymer network as oral delivery vehicles. International Journal of Pharmaceutics . 2008
  • 4MOUNIR S M,SULOCHANA P,FOTIS P.Oral absorption of insulin encapsulated in artificial chyles of bile salts,palmitic acid andα-tocopherol dispersions. International Journal of Pharmaceutics . 2002
  • 5Iwanaga K,Ono S,Narioka K,et al.Oral delivery of insulin by using surface coating liposomes improvement of stability of insulin in GI tract. International Journal of Pharmaceutics . 1997
  • 6Takeuchi H,Yamamoto H,Kawashima Y.Mucoadhesive nanoparticulate systems for peptide drug delivery. Advanced Drug Delivery Reviews . 2001
  • 7Yoshinori Onuki,Mariko Morishita and Kozo Takayama.Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. Journal of Controlled Release . 2004
  • 8Kirby CJ.Oil-Based formulations for oral delivery of therapeutic peptides. J Liposome Res . 2000
  • 9Furtado S,Abramson D,Burrill R,et al.Oral delivery of insulin loaded poly(fumaric-co-sebacic)anhydride microspheres. International Journal of Pharmaceutics . 2008

二级参考文献22

  • 1祁荣,平其能,徐瑞阳,石勇平.酪蛋白和鱼精蛋白对胰岛素酶降解和口服降血糖作用的影响[J].药学学报,2004,39(10):844-848. 被引量:6
  • 2吴正红,平其能,宋赟梅,雷晓敏,李建英,蔡鹏.壳聚糖和壳聚糖EDTA接合物双层包覆胰岛素口服纳米脂质体的研究[J].药学学报,2004,39(11):933-938. 被引量:13
  • 3Watnasirichaikul S,Rades T,Tucker I G,et al.In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion [J].J Pharm Pharmacol,2002,54:473-480.
  • 4Cournarie F,Savelli M P,Rosilio V,et al.Insulin-loaded W/O/W multiple emulsions:comparison of the performances of systems prepared with medium-chain-triglycerides and fish oil [J].Eur J Pharm Biopharm,2004,58:477-482.
  • 5Kim B Y,Jeong J H,Park K,et al.Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin-microparticle conjugates in oral insulin delivery system [J].J Control Release,2005,102:525-538.
  • 6Mesiha M S,Sidhom M B,Fasipe B.Oral and subcutaneous absorption of insulin poly(isobutylcyanoacrylate) nanoparticles [J].Int J Pharm,2005,288:289-293.
  • 7Merisko-Liversidge E,McGurk S L,Liversidge G G.Insulin nanoparticles:a novel formulation approach for poorly water soluble Zn-insulin [J].Pharm Res,2004,21:1545-1553.
  • 8Li C L,Deng Y J.Oil-based formulations for oral delivery of insulin [J].J Pharm Pharmacol,2004,56:1101-1107.
  • 9Hosny E A,Al-Shora H I,Elmazar M M.Oral delivery of insulin from enteric-coated capsules containing sodium salicylate:effect on relative hypoglycemia of diabetic beagle dogs [J].Int J Pharm,2002,237:71-76.
  • 10Krauland A H,Guggi D,Bernkop-Schnurch A.Oral insulin delivery:the potential of thiolated chitosan-insulin tablets on non-diabetic rats [J].J Control Rel,2004,95:547-555.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部